J R Curtis|S Borson - JoVE Visualize

Showing results (71-80 of 188) with videos related to

Pageof 19

Sort By:

JAMA|January 11, 1995

Use of the medical futility rationale in do-not-attempt-resuscitation ordersJ R Curtis, D R Park, M R Krone, et al.

Thrombosis and Haemostasis|April 30, 1986

The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessmentH Ireland, D A Lane, A Flynn, et al.

Archives of Internal Medicine|June 10, 2000

The attitudes of patients with advanced AIDS toward use of the medical futility rationale in decisions to forego mechanical ventilationJ R Curtis, D L Patrick, E S Caldwell, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1986

Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formationD A Lane, H Ireland, A Flynn, et al.

Clinical Nephrology|December 1, 1989

A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparinE Anastassiades, D A Lane, H Ireland, et al.

Journal of Affective Disorders|March 1, 1986

Depression and physical illness among elderly general medical clinic patientsW A Kukull, T D Koepsell, T S Inui, et al.

AIDS (London, England)|July 9, 1999

The quality of patient-doctor communication about end-of-life care: a study of patients with advanced AIDS and their primary care cliniciansJ R Curtis, D L Patrick, E Caldwell, et al.

British Medical Journal (Clinical Research Ed.)|April 17, 1982

Acute haemolysis due to concentrated dialysis fluidI Mulligan, P Parfrey, M E Phillips, et al.

British Journal of Haematology|November 1, 1988

Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222C J Tew, D A Lane, E Thompson, et al.

Acta Chirurgica Scandinavica. Supplementum|January 1, 1988

Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failureD A Lane, H Ireland, C J Tew, et al.

Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:

Pageof 19

JAMA|January 11, 1995

Use of the medical futility rationale in do-not-attempt-resuscitation ordersJ R Curtis, D R Park, M R Krone, et al.

Thrombosis and Haemostasis|April 30, 1986

The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessmentH Ireland, D A Lane, A Flynn, et al.

Archives of Internal Medicine|June 10, 2000

The attitudes of patients with advanced AIDS toward use of the medical futility rationale in decisions to forego mechanical ventilationJ R Curtis, D L Patrick, E S Caldwell, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1986

Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formationD A Lane, H Ireland, A Flynn, et al.

Clinical Nephrology|December 1, 1989

Journal of Affective Disorders|March 1, 1986

Depression and physical illness among elderly general medical clinic patientsW A Kukull, T D Koepsell, T S Inui, et al.

AIDS (London, England)|July 9, 1999

The quality of patient-doctor communication about end-of-life care: a study of patients with advanced AIDS and their primary care cliniciansJ R Curtis, D L Patrick, E Caldwell, et al.

British Medical Journal (Clinical Research Ed.)|April 17, 1982

Acute haemolysis due to concentrated dialysis fluidI Mulligan, P Parfrey, M E Phillips, et al.

British Journal of Haematology|November 1, 1988

Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222C J Tew, D A Lane, E Thompson, et al.

Acta Chirurgica Scandinavica. Supplementum|January 1, 1988

Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failureD A Lane, H Ireland, C J Tew, et al.

Pageof 19